Amy VanMeter
George Mason University · 17 works · 1,557 citations · h-index 8
Top works
- Laser-capture microdissection
- A Genomic and Proteomic Study of the Spectrum of Nonalcoholic Fatty Liver Disease *
- Students Who Demonstrate Strong Talent and Interest in STEM Are Initially Attracted to STEM through Extracurricular Experiences
- An Initial Characterization of the Serum Phosphoproteome
- Reverse-phase protein microarrays: application to biomarker discovery and translational medicine
- Reverse Phase Protein Microarrays
- The Heme Degradation Pathway is a Promising Serum Biomarker Source for the Early Detection of Alzheimer's Disease
- Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALL
- Abstract 1542: CD38 is physically associated with CD49d and enhances CD49d-mediated adhesion of B-Cell chronic lymphocytic leukemia cells
- 2.29 Circulating CLL Cells Expressing Markers of Clinical Aggressiveness Display a Phosphoproteomic Profile Consistent with a Constitutive Receptor Engagement
- Use of an ex vivo multiplexed signal pathway inhibitor treatment to reveal sensitivity of myeloma and nonmyeloma bone marrow cell populations.
- Protein signal pathway mapping: Screening potential drug targets for Multiple Myeloma
- Ex Vivo Multiplexed Signal Pathway Inhibitor Treatment Reveals Differential Sensitivity of Myeloma and Non-Myeloma Bone Marrow Cell Populations.
- Circulating CLL Cells Expressing CD49d Display a Phospho-Proteomic Profile Consistent with a Constitutive Receptor Engagement by Blood-Borne Ligands
- P3‐015: Identification of serum biomarker candidates for Alzheimer's disease
- Abstract 1265: Tissue is alive: Preserving phosphoproteins and tissue morphology in clinical trial samples